These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15554141)

  • 1. [A use of betaserc in ataxic syndromes].
    Prokopenko SV; Rudnev VA; Afanas'eva EV; Abramov VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):41-5. PubMed ID: 15554141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Betaserc and improvement of life quality in war veterans].
    Larikova TI; Cherevikova GM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):68-70. PubMed ID: 15822746
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-neurological and stabilometric analysis of betahistine (betaserc) efficacy in the patients with vertigo in the rehabilitation period of ischemic stroke].
    Gekht AB; Vialkova AB; Galanov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():32-8. PubMed ID: 16447551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].
    Berdichevskiĭ MIa; Karmirian SA; Geĭko II; Miroshnichenko VE; Parkhaeva TN; Popova VG; Timchenko LV; Filina TV; Aristova LA
    Vestn Otorinolaringol; 2002; (4):32-3. PubMed ID: 12400131
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo.
    Albera R; Ciuffolotti R; Di Cicco M; De Benedittis G; Grazioli I; Melzi G; Mira E; Pallestrini E; Passali D; Serra A; Vicini C
    Acta Otolaryngol; 2003 Jun; 123(5):588-93. PubMed ID: 12875580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vertigo: patient management tactics].
    Vasyl'chuk IS; Kozlova OO; Trinus KF; Holovchenko IuI; Slobodin TM
    Lik Sprava; 2012; (7):84-7. PubMed ID: 23350121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
    Popova NF; Chugunova MA; Kunel'skaia NL; Shagaev AS; Boĭko AN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):77-81. PubMed ID: 21916160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of vertigo with betahistine and its clinical and electrophysiological evaluation].
    Wasilewska H; Domzał TM
    Neurol Neurochir Pol; 1999; 33(1):63-9. PubMed ID: 10399725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Betaserk in the treatment of aftereffects of craniocerebral injury and vascular events].
    Odinak MM; Kovalenko AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):55-7. PubMed ID: 16117150
    [No Abstract]   [Full Text] [Related]  

  • 10. [Betaserc treatment of psychogenic vertigo].
    Solov'eva AD; Kornilova LN; Akarachkova ES; Temnikova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(7):39-42. PubMed ID: 15347033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effectiveness of betahistine in monotherapy of vertigo for different etiology].
    Nowak K; Szymiec E
    Otolaryngol Pol; 2006; 60(6):981-4. PubMed ID: 17357686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.
    Lacour M; Sterkers O
    CNS Drugs; 2001; 15(11):853-70. PubMed ID: 11700150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A variant of monotherapy in vertigo and subjective noise in the ears].
    Golubovskiĭ OA; Fedorova OV
    Vestn Otorinolaringol; 2002; (4):34-5. PubMed ID: 12400132
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assessment of betahistine dihydrochloride effectiveness in the treatment of vertigo of a different aetiology based on videonystagmography test results].
    Kantor I; Jurkiewicz D
    Pol Merkur Lekarski; 2006 Mar; 20(117):318-21. PubMed ID: 16780265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rehabilitation of patients with peripheral vestibular disorders].
    Morozova SV; Zaĭtseva OV
    Vestn Otorinolaringol; 2004; (2):59-61. PubMed ID: 15139364
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cerebral hemodynamics and statokinetic functions in patients with vertebral basilar vascular insufficiency].
    Butko DIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):38-42. PubMed ID: 15847325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of vertigo with betaserk in patients with vascular and traumatic cerebral injuries].
    Gusev EI; Nikonov AA; Skvortsova VI; Avakian GN; Gordeeva TN; Katunina EA; Ataian AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(11):19-21. PubMed ID: 9845935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of Betaserc in auditory and vestibular disturbances.
    Petrova D; Sachansca T; Datcov E
    Int Tinnitus J; 2004; 10(2):177-82. PubMed ID: 15732519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effectiveness of maneuvers and medication in the treatment of benign paroxysmal positional vertigo.
    Itaya T; Yamamoto E; Kitano H; Yazawa Y; Kitajima K
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(3):155-8. PubMed ID: 9186970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betahistine in vertebrobasilar insufficiency.
    Kaźmierczak H; Pawlak-Osińska K; Kaźmierczak W
    Int Tinnitus J; 2004; 10(2):191-3. PubMed ID: 15732521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.